Role of the SR/ER E3 Ubiquitin Ligase Synoviolin 1 in Cardiac Hypertrophy
SR/ER E3 泛素连接酶 Synoviolin 1 在心脏肥大中的作用
基本信息
- 批准号:9102175
- 负责人:
- 金额:$ 37.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-07-01 至 2019-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdenovirusesAffectAtrophicAttenuatedCardiacCardiac MyocytesCardiovascular DiseasesCell NucleusCessation of lifeDataDevelopmentDiseaseDisease ProgressionEndoplasmic ReticulumEquilibriumFutureGene DeliveryGene ExpressionGene TransferGenesGoalsGrowthHealthHeartHeart HypertrophyHeart failureHypertrophyInnovative TherapyIntegral Membrane ProteinInterventionKnowledgeLeadLifeLocationMeasuresMediatingMethodsMissionMolecularMusMyocardial dysfunctionPathway interactionsPhosphotransferasesProcessProtein BiosynthesisProteinsPublic HealthQuality ControlRegulationResearchRoleSgk proteinSignal TransductionSignaling ProteinStimulusStressSystemThinkingTimeTissuesUbiquitinationUnited States National Institutes of HealthViraladenoviral-mediatedbasecell growthclinically relevantdesignheart dimension/sizein vivoinnovationloss of functionmembernoveloverexpressionpressureprotein degradationprotein foldingprotein misfoldingresponsesymptom treatmenttranscription factortranscriptomeubiquitin ligaseubiquitin-protein ligase
项目摘要
DESCRIPTION (provided by applicant): Pathological hypertrophic growth of cardiac myocytes can lead to heart failure; inhibiting this growth can avert heart failure. While we have a good understanding of growth-activating processes in the heart, there is a gap in our understanding of growth-inhibiting processes. The objective of this proposal is to address this gap by examining the protein quantity and quality control (PQQC) system in the sarco/endoplasmic reticulum (SR/ER) of cardiac myocytes, which we have shown can moderate cardiac myocyte growth. This objective aligns with our long-term goal of defining innovative strategies for averting heart failure by reducing pathological hypertrophy. We found that a key member of the SR/ER PQQC system, the transcription factor, ATF6, decreases cardiac myocyte hypertrophy. ATF6, which is also cardioprotective, is an SR/ER transmembrane (TM) protein that senses growth signals. We showed that ATF6 induces the SR/ER TM E3 ubiquitin (Ub) ligase, synoviolin (Syvn1); SR/ER TM Ub ligases have not been studied in the heart. Surprisingly, Syvn1 did not affect global protein ubiquitination or degradation, but it decreased cardiac myocyte hypertrophy in response to growth stimuli. The hypothesis is that Syvn1 decreases toxic protein misfolding by targeting terminally misfolded proteins made in the SR/ER for degradation. Moreover, Syvn1 can target select signaling proteins for degradation, such as the cytosolic growth-promoting kinase, serum/glucocorticoid-regulated kinase 1, SGK1, and that these functions contribute to the ability of Syvn1 to moderate cardiac hypertrophy. The approach will use viral-mediated gene transfer to cultured cardiac myocytes and to mouse hearts, in vivo, to examine the effects of Syvn1 gain- and loss-of-function. The specific aims are to examine the effects of Syvn1- gain- or loss-of-function on 1) cardiac hypertrophy, 2) the degradation of misfolded SR/ER proteins during cardiac myocyte hypertrophy, and 3) the level, location and activity of SGK1, and its impact on cardiac myocyte hypertrophy. The proposed studies are expected to show that, as a regulator of PQQC, Syvn1 contributes to balancing protein synthesis and protein folding capacity. These results will be significant because they will reveal novel mechanisms of inhibiting hypertrophy, and they will identify new targets for HF therapy. The proposed research is innovative because roles for the SR/ER PQQC and, specifically, SR/ER TM E3 Ub ligases in growth regulation have not been examined in any tissue.
说明(申请人提供):心肌细胞病理性肥大生长可导致心力衰竭;抑制这种生长可避免心力衰竭。虽然我们对心脏中的生长激活过程有很好的了解,但我们对生长抑制过程的理解存在差距。这项建议的目的是通过检测心肌细胞肌浆网(SR/ER)中的蛋白质数量和质量控制(PQQC)系统来弥补这一差距,我们已经证明该系统可以调节心肌细胞的生长。这一目标与我们的长期目标一致,即确定通过减少病理性肥厚来避免心力衰竭的创新战略。我们发现,SR/ER PQQC系统的一个关键成员,转录因子ATF6,可以减少心肌细胞的肥大。ATF6也具有心脏保护作用,是一种感知生长信号的SR/ER跨膜(TM)蛋白。我们发现ATF6可诱导SR/ER TM E3泛素(Ub)连接酶SYVN1;SR/ER TM Ub连接酶在心脏中尚未被研究。令人惊讶的是,SYVN1没有影响全球蛋白质的泛素化或降解,但它减少了心肌细胞对生长刺激的肥大。假设SYVN1通过靶向SR/ER中产生的末端错误折叠的蛋白质进行降解,从而减少有毒蛋白质的错误折叠。此外,SYVN1可以针对特定的信号蛋白进行降解,如胞浆促生长蛋白、血清/糖皮质激素调节的激酶1、SGK1,这些功能有助于SYVN1调节中度心肌肥厚的能力。该方法将使用病毒介导的基因转移到培养的心肌细胞和体内的小鼠心脏,以检查SYVN1功能获得和丧失的影响。本研究旨在探讨SYVN1功能缺失与心肌肥大的关系,以及错折叠SR/ER蛋白在心肌肥大过程中的降解作用,以及SGK1在心肌肥厚过程中的水平、位置、活性及其对心肌细胞肥大的影响。这些研究有望表明,作为PQQC的调节者,SYVN1有助于平衡蛋白质合成和蛋白质折叠能力。这些结果将具有重要意义,因为它们将揭示抑制肥厚的新机制,并将确定HF治疗的新靶点。这项拟议的研究具有创新性,因为SR/ER PQQC,特别是SR/ER TM E3 Ub连接酶在生长调节中的作用尚未在任何组织中进行过研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Chris Glembotski其他文献
Chris Glembotski的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Chris Glembotski', 18)}}的其他基金
Non-canonical ERAD as a Regulator of Cardiac Hypertrophy
非典型 ERAD 作为心脏肥大的调节剂
- 批准号:
10544178 - 财政年份:2022
- 资助金额:
$ 37.5万 - 项目类别:
Non-canonical ERAD as a Regulator of Cardiac Hypertrophy
非典型 ERAD 作为心脏肥大的调节剂
- 批准号:
10817347 - 财政年份:2022
- 资助金额:
$ 37.5万 - 项目类别:
Non-canonical ERAD as a Regulator of Cardiac Hypertrophy
非典型 ERAD 作为心脏肥大的调节剂
- 批准号:
10363838 - 财政年份:2022
- 资助金额:
$ 37.5万 - 项目类别:
The ER Stress-Induced Selenoprotein, SelenoS, Regulates Proteostasis and Cardiac Hypertrophy
内质网应激诱导的硒蛋白 SelenoS 可调节蛋白质稳态和心脏肥大
- 批准号:
10550149 - 财政年份:2020
- 资助金额:
$ 37.5万 - 项目类别:
Harnessing the Adaptive ER Stress Response in Myocardial Ischemia
利用适应性 ER 应激反应治疗心肌缺血
- 批准号:
10227351 - 财政年份:2020
- 资助金额:
$ 37.5万 - 项目类别:
The ER Stress-Induced Selenoprotein, SelenoS, Regulates Proteostasis and Cardiac Hypertrophy
内质网应激诱导的硒蛋白 SelenoS 可调节蛋白质稳态和心脏肥大
- 批准号:
10322459 - 财政年份:2020
- 资助金额:
$ 37.5万 - 项目类别:
The ER Stress-Induced Selenoprotein, SelenoS, Regulates Proteostasis and Cardiac Hypertrophy
内质网应激诱导的硒蛋白 SelenoS 可调节蛋白质稳态和心脏肥大
- 批准号:
10218914 - 财政年份:2020
- 资助金额:
$ 37.5万 - 项目类别:
ATF6 is Required for ANP Secretion from the Heart
ATF6 是心脏分泌 ANP 所必需的
- 批准号:
10219762 - 财政年份:2018
- 资助金额:
$ 37.5万 - 项目类别:
Harnessing the Adaptive ER Stress Response in Myocardial Ischemia
利用适应性 ER 应激反应治疗心肌缺血
- 批准号:
9389978 - 财政年份:2017
- 资助金额:
$ 37.5万 - 项目类别:
Harnessing the Adaptive ER Stress Response in Myocardial Ischemia
利用适应性 ER 应激反应治疗心肌缺血
- 批准号:
9924642 - 财政年份:2017
- 资助金额:
$ 37.5万 - 项目类别:
相似海外基金
cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma
cGAS-STING 通路靶向具有 CD46 趋向性和 AFP 启动子的复制腺病毒条件性复制限制用于治疗肝细胞癌
- 批准号:
10436626 - 财政年份:2021
- 资助金额:
$ 37.5万 - 项目类别:
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
- 批准号:
10557162 - 财政年份:2021
- 资助金额:
$ 37.5万 - 项目类别:
Molecular therapy of replication-competent adenoviruses targeting characteristic gene mutations found in mesothelioma
针对间皮瘤中发现的特征基因突变的具有复制能力的腺病毒的分子疗法
- 批准号:
21K08199 - 财政年份:2021
- 资助金额:
$ 37.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
- 批准号:
10330464 - 财政年份:2021
- 资助金额:
$ 37.5万 - 项目类别:
Structural characterization of nucleoprotein cores of human adenoviruses
人腺病毒核蛋白核心的结构表征
- 批准号:
9807741 - 财政年份:2019
- 资助金额:
$ 37.5万 - 项目类别:
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
- 批准号:
41625-2013 - 财政年份:2018
- 资助金额:
$ 37.5万 - 项目类别:
Discovery Grants Program - Individual
The therapeutic strategies with augmented replications of oncolytic adenoviruses for malignant mesothelioma
溶瘤腺病毒增强复制治疗恶性间皮瘤的治疗策略
- 批准号:
18K15937 - 财政年份:2018
- 资助金额:
$ 37.5万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
- 批准号:
41625-2013 - 财政年份:2017
- 资助金额:
$ 37.5万 - 项目类别:
Discovery Grants Program - Individual
Exploring the effects of nutrient deprivation on T cells and oncolytic adenoviruses, in order to create immune activators for tumour therapy
探索营养剥夺对 T 细胞和溶瘤腺病毒的影响,以创造用于肿瘤治疗的免疫激活剂
- 批准号:
1813152 - 财政年份:2016
- 资助金额:
$ 37.5万 - 项目类别:
Studentship
Research on detection of novel adenoviruses by genetic methods
新型腺病毒的基因检测研究
- 批准号:
16K09118 - 财政年份:2016
- 资助金额:
$ 37.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)